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One-third of global deaths result from cardiovascular dis-
eases1 with the vast majority of cardiovascular disease deaths 
in low-middle income countries.2 China has recently experi-
enced major increases in ischemic heart disease and stroke,3 
concomitant with multiple health care system reforms.4,5 
While 300 million individuals in China are estimated to have 
high blood pressure (BP),6 over half are undiagnosed and 
untreated,7–10 leading to substantial health and economic 
burden.11 It is unknown whether efforts to reduce hyperten-
sion burden in China would be more effective if directed at 
hypertension diagnosis or treatment.
Much of the literature considers each step in the continuum 
from elevated BP to hypertension diagnosis and hyperten-
sion treatment as discrete unrelated steps, generally using 
standard logistic regression models.9 There are papers solely 
on hypertension, others just on diagnosis, and yet others on 
treatment. No analyses consider the full sequence from hav-
ing elevated BP, to hypertension diagnosis, to hypertension 
treatment, while addressing differential effects at each stage 
and taking each previous step into account (i.e., hyperten-
sion treatment conditional on diagnosis and elevated BP). It 
is likely that health insurance, health system availability, and 
socioeconomic factors may be differentially associated with 
elevated BP, diagnosis, and receiving treatment for hyperten-
sion. Yet, the vast majority of research uses separate logis-
tic regression models and ignores these important sources 
of selectivity and correlation between elevated BP, hyper-
tension diagnoses, and treatment, thus resulting in biased 
estimates.12 Further, most studies do not account for under-
lying, unobservable factors influencing who gets diagnosed 
Accounting for Selectivity Bias and Correlation Across the 
Sequence From Elevated Blood Pressure to Hypertension 
Diagnosis and Treatment
Penny Gordon-Larsen,1,2 Samantha M. Attard,1,2 Annie Green Howard,3 Barry M. Popkin,1,2 
Bing Zhang,4 Shufa Du,1,2 and David K. Guilkey PhD2,5 
BACKGROUND
It is unknown whether efforts to reduce hypertension burden in coun-
tries with very high prevalence, would be more effective if directed at 
hypertension diagnosis vs. treatment. Most analyses do not address 
bias and correlation across the sequence from elevated blood pressure 
(BP) to hypertension diagnosis and treatment, leading to potentially 
misleading findings.
METHODS
Using data spanning 18 years of the China Health and Nutrition Survey 
(n  =  18,926; ages 18–75  years), we used an innovative 3-step, inte-
grated system of equations to predict the sequence from: (i) elevated 
BP (systolic/diastolic BP ≥ 140/90 mm Hg) to (ii) diagnosed hyperten-
sion conditional on elevated BP, and to (iii) treatment (medication use) 
conditional on diagnosis, accounting for measured and unmeasured 
individual- and community-level confounders at each of the 3 steps. 
We compared results to separate traditional logistic regression models 
without control for unmeasured confounding.
RESULTS
Using our 3-step model, elevated BP increased from 12.6% and 8.5% 
(1991) to 36.8% and 29% (2009) in men and women, respectively, 
but diagnosis remained under 50%. We found widening disparities in 
hypertension diagnosis (higher hypertension at lower vs. higher educa-
tion (difference of 2% in 1991 that widened to 5% in 2009)) and narrow-
ing disparities in education (difference of 6% in 1991 to 4% in 2009) and 
insurance status (difference of 7% in 1991 to 2% in 2009) for treatment.
CONCLUSIONS
Our 3-step model improved model fit over traditionally used models. 
Our findings highlight serious barriers to hypertension diagnosis in 
Chinese adults, particularly among men and individuals of low attained 
education.
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and treated, despite the fact that health-consciousness, 
motivation, and demand for treatment clearly impact who 
visits the doctor and who receives treatment. Lack of such 
control limits understanding of the factors that differentially 
influence diagnosis and treatment.
We used a novel modeling strategy borrowing from tech-
niques used in economics used to evaluate effects of health 
programs with control for demand-based health program 
placement13,14 (garnering James Heckman the Economics 
Nobel Prize in 2000). We modified Heckman’s 2-step mod-
eling strategy15 to include 3 steps to examine factors associ-
ated with each of 3 steps in the continuum from elevated BP 
(systolic/diastolic BP (SBP/DBP) ≥ 140/90 mm Hg) to hyper-
tension diagnosis and subsequent treatment using 18 years of 
longitudinal data from the population-based China Health 
and Nutrition Survey (n = 19,509 adults seen over 7 exams 
between 1991 and 2009), accounting for measured and 
unmeasured confounders (i.e., unobservable factors with dif-
ferential influence on elevated BP, hypertension diagnosis, and 
treatment). In addition, we compared these results to separate 
logistic regression models, with the same measured confound-
ers but without correction for unmeasured confounders.
METHODS
China Health and Nutrition Survey (CHNS)
The C HNS i s a  longitudinal s tudy of 2 28 c ommunities 
within 9 provinces of China. Surveys began in 1989, with 
subsequent surveys every 2 to 4 years, for a total of 8 rounds 
of surveys between 1989 and 2009. The CHNS was designed 
to provide representation of rural, urban, and suburban 
areas varying substantially in geography, economic develop-
ment, public resources, and health indicators with a focus on 
examining changes in dietary behavior, physical activity, and 
health in the context of urbanization and economic change.16 
It is the only large-scale, longitudinal study of its kind in 
China. The original 1989 survey used a multistage, random 
cluster design in 8 provinces (Liaoning, Jiangsu, Shandong, 
Henan, Hubei, Hunan, Guangxi, and Guizhou) to select a 
stratified probability sample. Using this sampling strategy, 2 
cities (1 large and 1 small city—usually the provincial cap-
ital and a lower income city) and 4 counties (stratified by 
income: 1 high, 1 low, and 2 middle income counties) were 
selected. Within cities, 2 urban and 2 suburban communities 
were selected; within counties, 1 community in the capital 
city and 3 rural villages were chosen. Twenty households 
per community were then randomly selected for participa-
tion. The study met the standards for the ethical treatment 
of participants and was approved by the Institutional Review 
Boards of the University of North Carolina at Chapel Hill 
and the Institute of Nutrition and Health, Chinese Center 
for Disease Control and Prevention. More detailed survey 
procedures have been described elsewhere.16
Sample
The eligible sample included 19,509 adults aged 
18–75 years with SBP and DBP data for at least one of the 
1991, 1993, 1997, 2000, 2004, 2006, and 2009 exams (60,289 
observations). Of these individuals, 18,926 (56,843 observa-
tions [obs]) had complete covariate data on 1 to 7 measure-
ment occasions and were included in the analysis. Subjects 
were excluded due to pregnancy at time of survey (n = 105) 
or missing hypertension diagnosis (n = 150), health insur-
ance (n  =  31), education (n  =  230), or household income 
(n  =  67). Some individuals had more than one covariate 
missing at more than one occasion. Relative to the full eli-
gible sample (n = 19,509), the analytic sample (n = 18,926) 
was comprised of a greater proportion of males, older indi-
viduals, and those of higher education and income, who 
lived in areas of lower urbanization; individuals missing 
hypertension diagnosis or treatment information at one or 
more waves (n  =  1,471) tended to be female, have higher 
SBP or DBP, lower attained education or income, and live in 
communities of lower urbanization.
Outcome measures
At each survey, experienced physicians measured SBP and 
DBP in triplicate on the right arm using an appropriately 
sized cuff from a standard mercury sphygmomanometer 
after 5-minute initial seated rest, with 30-second interval 
between measurements and mean SBP and DBP calculated. 
Hypertension was defined as having self-reported doctor 
diagnosis of hypertension, use of antihypertensive medica-
tion, SBP ≥140 mm Hg, or DBP ≥90 mm Hg17 and undiag-
nosed hypertension as SBP/DBP ≥140/90 mm Hg without 
doctor diagnosis of hypertension. Diagnosed hypertension 
defined as self-reported doctor diagnosis of hypertension 
without reported hypertension medication use and treated 
hypertension as self-report of the use of antihypertension 
medication.
Individual-level covariates
Age, sex, highest attained education, health insurance 
availability, and type were self-reported at each survey using 
standard survey procedures. Income was reported at the 
household and individual levels at each survey and inflated 
to the 2009 yuan currency for comparability over time.
Community-level covariates
A validated community-level, multidimensional urban-
ization index18 comprised of 12 components (transportation 
infrastructure, health infrastructure, population density, 
economic activity, sanitation, education, education and 
income diversity, social services, sanitation infrastructure, 
housing infrastructure, communications, modern markets, 
and traditional markets) was derived from household and 
community survey questions at each wave. The community-
level price for 100 pills of capoten, a commonly prescribed 
Angiotensin-Converting-Enzyme inhibitor, was calculated 
from prices in community drug stores in 2000 and 2004 and 
community pharmacies in 2006 and 2009. Provinces were cat-
egorized into 3 regions [northern (Liaoning, Heilongjiang), 
central (Jiangsu, Shandong, Henan), or southern (Guangxi, 
Guizhou, Hubei, Hunan)].
Analyses
Descriptive analyses were conducted in Stata 12 (Stata 
Corp, College Station, TX). Selection models were estimated 
in Absoft Pro Fortran 11.1 (Absoft Development Tools and 
Languages, Rochester Hills, MI). In descriptive analyses, we 
examined individual- and community-level characteristics 
according to survey year and by hypertension status (nor-
motension, undiagnosed, diagnosed, treated) using analysis 
of variance for continuous variables and chi-squared tests 
for categorical variables.
We modified Heckman’s method to involve joint esti-
mation of 3 equations (rather than 2 in Heckman’s original 
work) and the use of a semi-parametric estimator rather 
than assuming joint normality as was done in the original 
Heckman paper. The joint estimation controls for the cor-
relation in unobserved variables that affect the selection and 
the resulting reduction in bias has been well documented in 
the literature.19,20 We used this 3-step Heckman-type selec-
tion model12 to predict (step 1) elevated BP, (step 2) hyper-
tension diagnosis, and (step 3)  hypertension treatment, 
while accounting for measured and unmeasured confound-
ing at the individual and community levels (including access 
to community-level health infrastructure) in each of the 3 
model steps.12,13 Rather than assuming a specific distribution 
such as multivariate normality for the unobserved hetero-
geneity (i.e., confounding by unobservable factors) at the 
community and individual levels, we used a discrete factor 
approximation with 5 points of support for both distribu-
tions as a more robust19 extension of Heckman and Singer.15
To deal with selectivity in the sequence of elevated BP, 
diagnosis, and treatment, each step of the Heckman selec-
tion model included exogenous factors (i.e., observed con-
founders), and an unobserved heterogeneity component 
(i.e., correction for unmeasured confounders). We did not 
include statistical mediators, such as smoking, body mass 
index, and diet since adjusting for mediating variables can 
introduce bias to coefficient estimates.21,22
The model for elevated BP included: time (years since base-
line), age in 2000, squared age in 2000, interactions between 
time and age, household income and its interaction with 
time, health insurance and its interaction with time, high-
est attained education, region, and community-level urban-
ization covariates: access to communications infrastructure, 
health infrastructure, modern markets, and traditional mar-
kets; quality of housing infrastructure, social services, and 
transportation infrastructure and sanitation infrastructure; 
income and education diversity; and population density. The 
hypertension diagnosis model did not include region and 
certain community-level variables (housing infrastructure, 
sanitation infrastructure, presence of modern markets, and 
presence of traditional markets) that were in the elevated BP 
model on the basis of differences in predictors of elevated BP 
and diagnosis (e.g., availability of fast food may be associated 
with elevated BP, but not with diagnosis of hypertension), 
and because including different covariates for each step in 
the Heckman-type selection model aids identification of 
the system of equations. The hypertension treatment model 
included all covariates from the hypertension diagnosis 
model, with the addition of hypertension medication price 
(low, medium, high, or missing) under the assumption that 
community-level medication prices would not be associated 
with elevated BP or diagnosis, but could be associated with 
hypertension medication use. We compared results from the 
3-step model to 3 separate, traditional logistic regression
models (Supplementary Table 1). We call these models naïve
results as they controlled for the same measured confound-
ers but did not include control for unmeasured confounding
across each step in the continuum from undiagnosed hyper-
tension to hypertension diagnosis to treated hypertension.
We examined model fit statistics to determine whether 
correction for unobservable factors was necessary (details 
and results presented in Supplementary Methods and Table).
Presentation of results
Using regression coefficients from the 3-step model sys-
tem, we predicted: (i) elevated BP, (ii) hypertension diagno-
sis conditional on having elevated BP, and (iii) hypertension 
treatment conditional on hypertension diagnosis, according 
to sex, attained education, and health insurance. While we 
included the full analytic sample for model estimation, we 
present simulations for individuals aged 36–75 years in 2009 
(n = 7,135) to hold observed characteristics of the same indi-
viduals constant over time. We used a parametric bootstrap-




The crude prevalence of hypertension in adults aged 
18–75 years doubled from 13.2% in 1991 to 28.4% in 2009, 
coupled with an increase in BMI, income, and urbaniza-
tion (Table 1). By 2009, almost 10% of the sample reported 
receiving treatment via the use of hypertension medication 
(Table  1). Unadjusted baseline characteristics suggest dif-
ferences in hypertension status by education level, age, sex, 
urbanization, and health insurance (Table 2).
Model-based findings
Findings for the first step of the Heckman selection 
model (elevated BP) suggest higher odds of hypertension for 
men than women (Table 3). The odds ratios for hyperten-
sion were higher for individuals with secondary or greater 
attained education relative to individuals with primary 
attained education.
In the second step of the Heckman selection model 
(hypertension diagnosis among individuals with elevated 
BP), more women than men were diagnosed with hyperten-
sion; more individuals with primary or greater (vs. less than 
primary) attained education were diagnosed with hyperten-
sion (Table 3).
In the third step of the Heckman selection model (hyper-
tension treatment among individuals diagnosed with hyper-
tension), women were more likely than men to be treated for 
hypertension (Table 3).
Given the complexity of interpreting these findings jointly 
across the 3 equations, with results conditional on the pre-
vious step, we used simulations based on our model coef-
ficients to predict elevated BP, diagnosis, and treatment of 
hypertension across key covariates.
Our simulations by education (Figure 1) showed higher 
hypertension prevalence in individuals of lower (vs. higher) 
attained education (difference of 2% in 1991 that widened 
to 5% in 2009). However, diagnosis (conditional on having 
elevated BP) was higher in individuals of higher (vs. lower) 
education (difference o f 7% in 1991 that w idened to 10% 
in 2009). Yet, educational differences in treatment (condi-
tional on having elevated BP and diagnosis of hypertension) 
narrowed over time in lower (vs. higher) attained education 
(from 6% in 1991 to 4% in 2009).
Similarly, our model-based simulations suggest a rever-
sal in progression in men vs. women over time 
(Figure 2). 
Men had higher predicted hypertension prevalence than 
women at all time points, with differences that widened 
over time (4% in 1991 to 8% in 2009). However, women 
had higher predicted hypertension diagnosis conditional 
on having hypertension and higher treatment conditional 
on diagnosis than men. These differences narrowed over 
time, from 4% in 1991 to 3% in 2009 for diagnosis and 
treatment.
Differences in predicted prevalence, diagnosis (condi-
tional on having elevated BP), and treatment (conditional 
on having elevated BP and diagnosis of hypertension) were 
consistent in individuals with and without health insur-
ance (Figure 3). These simulations suggest higher treatment 
among the insured (vs. uninsured), with narrowing differ-
ences in treatment (conditional on having elevated BP and 
diagnosis of hypertension) by insurance status over time 
(from 7% in 1991 to 2% in 2009).
Table 1. Analytic sample characteristics of Chinese adults (aged 18–75 years) according to CHNS survey year
Total 1991 1997 2004 2009
n = 56,843 n = 7,612 n = 7,885 n = 8,573 n = 8,748
Women, % 52.0 52.7 50.9 51.9 52.2
Age in years, mean (SD) 44.5 (14.4) 39.9 (14.4) 42.4 (14.4) 46.7 (13.9) 48.6 (13.7)
Household income (in hundreds)  
(2009 Yuan), (SD)
197.5 (323.4) 58.3 (66.5) 144.5 (127.7) 213.9 (221.8) 415.8 (603.2)
BMI kg/m2, mean (SD) 22.7 (3.23) 21.7 (2.9) 22.3 (3.1) 23.1 (3.3) 23.4 (3.4)
SBP mm Hg, mean (SD) 119.1 (18.0) 114.0 (17.7) 118.3 (17.6) 121.7 (18.2) 123.6 (18.1)
DBP mm Hg, mean (SD) 77.5 (11.2) 74.1 (11.2) 77.0 (11.0) 78.6 (11.2) 80.4 (11.1)
Hypertension status,a %
 Normotension 79.6 86.8 81.0 76.7 71.6
 Hypertension 20.4 13.2 19.0 23.3 28.4
  Undiagnosed 13.3 8.9 15.1 14.9 16.5
  Diagnosed 2.1 1.9 1.3 2.3 2.4
 Treated 5.1 2.4 2.6 6.1 9.5
Community-level measures,b mean (SD)
Total urbanization,c 57.8 (20.0) 46.8 (16.2) 53.0 (18.2) 62.7 (20.3) 67.1 (19.4)
Population density 5.8 (1.5) 5.8 (1.3) 5.6 (1.5) 5.8 (1.6) 5.9 (1.5)
 Communication 5.3 (1.7) 3.9 (1.4) 4.7 (1.3) 5.7 (1.5) 6.8 (1.5)
Educational and economic diversity 4.6 (1.2) 3.8 (1.0) 4.2 (1.0) 4.7 (1.2) 5.4 (1.1)
Health infrastructure 5.6 (2.3) 5.7 (2.0) 5.8 (2.2) 5.3 (2.3) 5.9 (2.6)
Social services 1.7 (2.4) –d –d 2.9 (2.5) 3.6 (3.1)
Transportation infrastructure 5.6 (2.6) 4.9 (3.0) 5.4 (2.6) 5.9 (2.4) 5.9 (2.1)
Proportion of population with health  
insurance, %
40.1 34.0 26.4 27.5 91.4
Abbreviations: BMI, body mass index; CHNS, China Health and Nutrition Survey; DBP, diastolic blood pressure; SBP, systolic blood pressure.
aNormotension defined as SBP/DBP <140/90 mm Hg. Undiagnosed hypertension defined as SBP/DBP ≥140/90 mm Hg without doctor 
diagnosis of hypertension. Diagnosed hypertension defined as self-reported doctor diagnosis of hypertension without reported hypertension 
medication use. Treated hypertension defined as self-report of the use of hypertension medication.
bCommunity-level measures are derived from community-level surveys taking place every year in the CHNS. Each measure has a possible 
range of 0–10, with a higher score indicating higher urbanization.17
cUrbanization based upon a 12-component urbanization scale (possible range: 0–120) formed specifically for the CHNS. Omitted from table: 
economic activity, sanitation, education, traditional markets, modern markets.
dSocial services data collected from 2004 onward.
In contrast, naïve, logistic regression models (Table  4) 
suggest that the lack of control for unmeasured confounders 
resulted in comparatively stronger differences in treatment.
DISCUSSION
We aimed to determine whether efforts to reduce the 
burden of hypertension in China would be more effective if 
directed at hypertension diagnosis or at hypertension treat-
ment. Using our 3-step model, elevated BP increased from 
12.6% in 1991 to 36.8% in 2009 for men and from 8.5% in 
1991 to 29% in 2009 for women, but hypertension diagnosis 
remained under 50% for men and women at all time points. 
While previous studies have examined crude prevalence, 
diagnosis, and treatment of hypertension in China7,8,9,10 and 
worldwide,23–25 few studies have focused on social and demo-
graphic characteristics that differentially predict elevated BP, 
hypertension diagnosis and treatment, accounting for each 
of the previous steps.7,10 We found lower hypertension preva-
lence in individuals of higher (vs. lower) attained education, 
but higher diagnosis (conditional on having elevated BP) 
in individuals of higher (vs. lower) education with narrow-
ing of educational differences in treatment (conditional on 
having elevated BP and hypertension diagnosis). Treatment 
of hypertension among individuals with diagnosed hyper-
tension was more equitably distributed (though differences 
were still present); almost 80% of individuals (across all SES 
levels) with diagnosed hypertension were treated.
Our model-based findings suggest that despite multiple 
health care reforms in China over recent decades, notable 
education and sex disparities in hypertension prevalence 
and diagnosis remain, and have widened. Thus, hypertension 
diagnosis remains the major barrier to improving BP control 
in China, even after controlling for access to health infra-
structure. Furthermore, population-level improvements in 
hypertension screening may hold a comparatively better 
advantage than intervening on treatment. In contrast, naïve 
logistic regression models showed smaller male–female dif-
ferences in elevated BP, but larger absolute differences in 
hypertension diagnosis. If our modeling approach is correct, 
it would mean that, findings from simple logistic regressions 
would erroneously suggest that education and sex dispari-
ties in hypertension diagnosis have decreased or remained 
constant over time, while differences in treatment persisted. 
These naïve findings would inappropriately lead to recom-
mendations to target hypertension treatment through avail-
ability or price reforms on hypertension treatment.
Previous cross-sectional examinations of hypertension 
prevalence and diagnosis in China suggest that individuals 
of low (vs. high) education are more likely to have hyper-
tension and to be diagnosed.7,10 Similar to the United States, 
poorly educated Chinese adults are less able to afford health 
care and have more complications associated with uncon-
trolled, chronic disease than individuals of high education.5 
We found that hypertension diagnosis and treatment among 
hypertensive individuals was lower in men than women, 
which is consistent with previous studies in China7 and 
worldwide.26,27
Health insurance was more strongly associated with 
treatment than diagnosis particularly in early survey 
years, though model coefficients were not statistically 
significant. Universal health insurance reforms were 
implemented in 2006; by 2009, >90% of adults across 
China (and in the CHNS) were insured, though insurance 
quality varies greatly.5,28 Approximately 80% of individu-
als diagnosed with hypertension were treated, but less 








N 6,609 677 143 183
Attained education, %
 <Primary 31.1 49.9 52.4 57.9 <0.0001
 Primary 51.6 38.3 42.0 (4.1) 24.6
 Secondary 12.3 7.2 3.5 (1.5) 9.3
>Secondary 5.0 4.6 2.1 (1.2) 8.2
Age in years, mean (SD) 37.9 (13.4) 51.9 (14.0) 52.6 (12.8) 58.0 (10.5) <0.0001
Urbanization, mean (SD)c 46.0 (16.2) 50.8 (15.6) 51.7 (15.3) 57.0 (13.4) <0.0001
Women, % 53.6 41.8 52.4 60.1 <0.0001
Income in hundreds of 2009 Yuan,  
mean (SD)
58.8 (69.7) 53.7 (37.3) 62.2 (47.2) 56.4 (37.1) 0.23
Health insurance, % 32.4 41.1 42.7 57.9 <0.0001
Abbreviations: ANOVA, analysis of variance; CHNS, China Health and Nutrition Survey.
aNormotension defined as systolic/diastolic blood pressure <140/90 mm Hg. Undiagnosed hypertension defined as systolic/diastolic blood 
pressure ≥140/90 mm Hg without doctor diagnosis of hypertension. Diagnosed hypertension defined as self-reported doctor diagnosis of hyper-
tension without reported hypertension medication use. Treated hypertension defined as self-report of the use of hypertension medication.
bP value for the difference in the explanatory variable across categories of normotension, undiagnosed hypertension, diagnosed hyperten-
sion, and treated hypertension using ANOVA tests for continuous variables or chi-squared test for categorical variables.
cUrbanization based upon a 12-component urbanization scale (possible range: 0–120) formed specifically for the CHNS.
than 50% of individuals with hypertension were diag-
nosed. Thus, increasing hypertension diagnosis through 
social or health insurance programs may hold a com-
paratively better health advantage than intervening at the 
treatment stage.
We compared our 3-step findings to 3 naïve separate 
logistic regressions, a modeling method typically found in 
the literature. Diagnostic testing indicated that unmeasured 
confounding was indeed present in the separate logistic 
models, yielding biased results. Accounting for unmeasured 
Table 3. Model coefficients from 3-step Heckman selection model in Chinese adults aged 18–75 years, CHNSa
Hypertension prevalence, 
coefficient (SE) P valueb
Hypertension diagnosis, 
coefficient (SE) P valueb
Hypertension 
treatment, 
coefficient (SE) P valueb
Parameter Obs = 56,843 Obs = 11,615 Obs = 4,073
Constant −0.05 (0.26) 0.39 −2.41 (0.33) <0.0001 −1.93 (0.43) <0.0001
Time 0.11 (0.01) <0.0001 0.12 (0.02) <0.0001 0.11 (0.02) <0.0001
Age in 2000 9.00 (0.43) <0.0001 10.13 (1.43) <0.0001 5.77 (2.38) 0.02
Age in 2000 * time 0.02 (0.03) 0.27 0.08 (0.08) 0.26 0.20 (0.14) 0.15
Age in 20002 3.49 (1.80) 0.06 −2.46 (4.41) 0.34 4.05 (6.94) 0.34
Age in 20002 * time −0.32 (0.13) 0.02 0.71 (0.30) 0.02 −0.69 (0.47) 0.13
Female −0.58 (0.05) <0.0001 0.24 (0.08) <0.01 0.16 (0.10) 0.11
Medium income −0.14 (0.09) 0.10 0.52 (0.19) <0.01 −0.44 (0.26) 0.09
High income −0.02 (0.09) 0.39 0.24 (0.19) 0.18 −0.56 (0.26) 0.04
Health insurance −0.04 (0.08) 0.35 −0.11 (0.17) 0.32 0.35 (0.23) 0.12
Health insurance * time 0.01 (0.01) 0.08 0.02 (0.01) 0.11 −0.01 (0.02) 0.352
Primary education −0.04 (0.05) 0.30 0.26 (0.09) <0.01 0.19 (0.12) 0.112
Secondary education −0.21 (0.08) <0.01 0.37 (0.14) <0.01 0.41 (0.19) 0.042
>Secondary education −0.38 (0.09) <0.0001 0.46 (0.15) <0.01 0.32 (0.20) 0.11
Communication 0.00 (0.02) 0.40 0.10 (0.03) <0.01 0.13 (0.04) <0.01
Population density 0.03 (0.02) 0.03 −0.03 (0.03) 0.23 0.00 (0.03) 0.40
Educational and income 
diversity
0.03 (0.02) 0.18 0.14 (0.03) 0.0001 0.07 (0.05) 0.14
Health infrastructure 0.03 (0.01) <0.01 0.03 (0.01) 0.07 0.07 (0.02) <0.01
Housing infrastructure 0.06 (0.01) <0.0001 – – – –
Traditional markets −0.01 (0.01) 0.11 – – – –
Social services −0.01 (0.01) 0.09 0.03 (0.01) 0.02 −0.02 (0.02) 0.26
Transportation 
infrastructure
0.01 (0.01) 0.18 0.03 (0.01) 0.04 0.04 (0.02) 0.06
Modern markets 0.02 (0.01) <0.01 – – – –
Sanitation infrastructure −0.02 (0.01) 0.02 – – – –
Central region −0.25 (0.05) <0.0001 – – – –
South region −0.79 (0.05) <0.0001 – – – –
Medium medication pricec – – – – 0.03 (0.12) 0.39
High medication pricec – – – – 0.15 (0.13) 0.21
Missing medication pricec – – – – 0.07 (0.21) 0.37
Medium income * time 0.01 (0.01) 0.272 −0.03 (0.01) 0.02 0.02 (0.02) 0.21
High income * time −0.00 (0.01) 0.372 −0.01 (0.01) 0.35 0.04 (0.02) 0.03
Abbreviations: BP, blood pressure; CHNS, China Health and Nutrition Survey.
aThree-step Heckman selection model for sequential estimation of hypertension prevalence, hypertension diagnosis, and hypertension treat-
ment, with 5 points of support, nonlinear error terms, and clustering at the individual and community levels.
bP values for z test of model coefficient.
cHypertension medication prices based upon pharmacy and drug-store prices for 100 pills of capoten, an ACE inhibitor, collected in 2000, 
2004, 2006, and 2009. An indicator variable for missing hypertension medication price was used for 1991, 1993, and 1997, when hypertension 
medication prices were not collected.
confounding in our 3-step model improved model fit and 
showed widening sex and education disparities in hyper-
tension diagnosis. Separate models for the 3 steps amplified 
differences in treatment, likely because this model did not 
control for confounding by hypertension diagnosis.
There are some limitations of note. Diagnosis and treat-
ment data were self-reported with misclassification a pos-
sibility as we do not know details regarding medication 
adherence, diagnosis misclassification due to respondents’ 
health literacy, or lack of doctor visits or screening. It is 
Figure 1. Predicted % from 3-step Heckman selection model according to attained education level from adults aged 18–75 years from China Health 
and Nutrition Survey 1991–2009. Three model outcomes were (a) hypertension prevalence (systolic/diastolic BP ≥ 140/90 mm Hg), (b) hypertension 
diagnosis (self-reported doctor diagnosis), and (c) hypertension treatment (self-reported medication use). Simulations were based on characteristics 
of the 2009 sample to hold constant individual characteristics over time. Model for hypertension treatment controlled for age, sex, household income, 
education level, and community-level: communication, population density, educational and income diversity, health infrastructure, social services, trans-
portation infrastructure, price of hypertension medication, and clustered at the community level. Model for hypertension diagnosis controlled for the 
same variables, except for price of hypertension medication. Model for hypertension prevalence controlled for the same variables as hypertension diag-
nosis, with additional control for region, and community level: housing infrastructure, traditional markets, modern markets, and sanitation infrastructure. 
Abbreviation: BP, blood pressure.
Figure 2. Predicted % from 3-step Heckman selection model according to sex from adults aged 18–75 years from China Health and Nutrition Survey 
1991–2009. Three model outcomes were (a) hypertension prevalence (systolic/diastolic BP ≥ 140/90 mm Hg), (b) hypertension diagnosis (self-reported 
doctor diagnosis), and (c) hypertension treatment (self-reported medication use). Simulations were based on characteristics of the 2009 sample to hold 
constant individual characteristics over time. Model for hypertension treatment controlled for age, sex, household income, education level, and commu-
nity-level: communication, population density, educational and income diversity, health infrastructure, social services, transportation infrastructure, price 
of hypertension medication, and clustered at the community level. Model for hypertension diagnosis controlled for the same variables, except for price 
of hypertension medication. Model for hypertension prevalence controlled for the same variables as hypertension diagnosis, with additional control for 
region, and community level: housing infrastructure, traditional markets, modern markets, and sanitation infrastructure. Abbreviation: BP, blood pressure.
possible that health insurance may have had a greater 
association with hypertension treatment because diag-
nosed individuals are likely to be more actively engaged 
in the health care system than undiagnosed individuals, 
although we controlled for factors such as community-
level health infrastructure. Future studies to assess exter-
nal validity of the 3-step modeling approach in other data 
sets is a next step.
We used a novel application of a well-established econo-
metric modeling strategy to examine how sex, education level, 
and health insurance are separately associated with hyperten-
sion prevalence, diagnosis, and treatment in Chinese adults. 
Our 3-step model had improved model fit over tradition-
ally used models. Our findings highlight serious barriers to 
hypertension diagnosis in Chinese adults, particularly among 
men and individuals of low attained education. Given rising 
Table 4. Comparing sign and P values of main exposure variables from 3-step Heckman Selection model vs. logistic regression models in 
Chinese adults aged 18–75 years, CHNSa
Hypertension prevalence Hypertension diagnosis Hypertension treatment
With correction Without correction With correction Without correction With correction Without correction
Female <0.0001 (−b) <0.0001 (−) <0.01 (+) <0.0001 (+) 0.11 (+) <0.01 (+)
Education
 Primary 0.30 (−) 0.17 (−) <0.01 (+) 0.01 (+) 0.11 (+) 0.15 (+)
 Secondary <0.01 (−) <0.01 (−) <0.01 (+) <0.01 (+) 0.04 (+) 0.09 (+)
>Secondary <0.0001 (−) <0.0001 (−) <0.01 (+) <0.001 (+) 0.11 (+) 0.13 (+)
Health insurance 0.35 (−) 0.20 (+) 0.32 (−) 0.17 (+) 0.12 (+) 0.03 (+)
Health insurance * time 0.08 (+) 0.40 (+) 0.11 (+) 0.35 (−) 0.36 (−) 0.17 (−)
Abbreviation: CHNS, China Health and Nutrition Survey.
aThree-step Heckman selection model for sequential estimation of hypertension prevalence, hypertension diagnosis, and hypertension treat-
ment had 5 points of support, nonlinear error terms, and clustering at the individual and household levels. Models additionally controlled for the 
confounders. The model for hypertension treatment controlled for age, household income, and community-level: communication, population 
density, educational and income diversity, health infrastructure, social services, transportation infrastructure, price of hypertension medication, 
and clustered at the community level. Model for hypertension diagnosis controlled for the same variables, except for price of hypertension medi-
cation. Model for hypertension prevalence controlled for the same variables as hypertension diagnosis, with additional control for region, and 
community level: housing infrastructure, traditional markets, modern markets, and sanitation infrastructure.
bA single plus and minus denotes the sign of the beta coefficient from the regression model.
Figure 3. Predicted % from 3-step Heckman selection model according to health insurance status from adults aged 18–75 years from China Health 
and Nutrition Survey 1991–2009. Three model outcomes were (a) hypertension prevalence (systolic/diastolic BP ≥ 140/90 mm Hg), (b) hypertension 
diagnosis (self-reported doctor diagnosis), and (c) hypertension treatment (self-reported medication use). Simulations were based on characteristics 
of the 2009 sample to hold constant individual characteristics over time. Model for hypertension treatment controlled for age, sex, household income, 
education level, and community-level: communication, population density, educational and income diversity, health infrastructure, social services, trans-
portation infrastructure, price of hypertension medication, and clustered at the community level. Model for hypertension diagnosis controlled for the 
same variables, except for price of hypertension medication. Model for hypertension prevalence controlled for the same variables as hypertension diag-
nosis, with additional control for region, and community level: housing infrastructure, traditional markets, modern markets, and sanitation infrastructure. 
Abbreviation: BP, blood pressure.
hypertension rates across rural and urban parts of China, and
the great health and economic costs of untreated hyperten-
sion, efficient diagnosis, and treatment of hypertension will
only increase in importance over the coming years.
SUPPLEMENTARY MATERIAL
Supplementary data are available at American Journal of 
Hypertension online.
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